Search results
GSK boasts win for depemokimab in asthma trials
Clinical Trials Arena via Yahoo Finance· 60 minutes agoThe pharma giant announced the drug met primary endpoints in both the SWIFT-1 (NCT04719832) and SWIFT-2 (NCT4718103) trials of a reduction in...
GSK's asthma drug shows promise in reducing severe attacks
Reuters· 5 hours ago, opens new tab asthma drug met its primary goal of reducing asthma attacks over a 52-week period in...
GSK's experimental drug shows promise in reducing severe asthma attacks
Reuters via AOL· 5 hours agoThe drug, called depemokimab, showed "significant and meaningful reductions" in asthma attacks for...
GSK Experimental Drug Reduces Severe Asthma Attacks in Key Trial
Bloomberg· 5 hours agoAn experimental drug from GSK Plc reduced asthma attacks in late-stage trials, paving the way for a...
Iron fuels immune cells – and it could make asthma worse
Arizona Daily Sun· 17 hours agoA lesser known important function of iron is its involvement in generating energy for certain immune...
Eosinophilic Asthma
Health via Yahoo News· 2 days agoThis type of asthma doesn't respond to traditional treatments, so other management techniques are necessary. Targeted therapies, such as biologics, are...
More Kids With Asthma Need Hospital Care on Very Hot Days
Homenewshere.com· 2 hours agoHeat waves and heat domes are particularly dangerous to kids with asthma, a new study finds. Daytime...
GSK says late-stage trials of potential blockbuster asthma drug met their goals
Market Watch· 4 hours agoGSK on Tuesday said two late-stage trials of an asthma drug that could have peak sales of more than...
GSK Sees Positive Results for Severe Asthma Treatment Depemokimab
The Wall Street Journal· 4 hours agoGSK said two late-stage trials of an asthma drug that could have peak sales of almost $4 billion met...
How are asthma and heart health linked?
Medical Xpress· 17 hours agoAsthma is a serious chronic disease in which airways are inflamed, often in response to specific triggers. "We call these major changes in the airways...
